Clinical Trials Browser

OTHER × Advanced Solid Tumors × 1 year × Clear all

NCT07438093 2026-02-27

Safety, Tolerability, and Preliminary Efficacy of Peginterferon α-2b in Combination With an Anti-PD-1 Antibody in Patients With Advanced or Metastatic Malignant Solid Tumors

Phase NA Not yet recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT05605496 2026-02-10

IMMUNONET

Phase 2 Active not recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT06556108 2026-01-20

ALPP CAR-T Cells for ALPP-Positive Advanced Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Advanced Solid Tumors

NCT07349160 2026-01-16

Safety and Efficacy of Metabolically Armed Tumor-Infiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT07285395 2025-12-16

AT1019 Plus SBRT and PD-1 Inhibitor for Advanced Solid Tumors: An IIT Study

Phase 1 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT06840821 2025-12-02

Evaluating the Safety, Tolerability, and Preliminary Anti-tumor Activity of MB0151 in Adult Subjects With Advanced Solid Tumors Expressing Somatostatin Receptors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT03191682 2025-09-25

A First-in-Human Study of PRL3-ZUMAB

Phase 1 Active not recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT07170787 2025-09-12

A Study of IMM2510 + IMM01 Combination Therapy in Patients With Advanced Solid Tumors

Phase 1/2 Not yet recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT07101549 2025-08-03

Treating Nectin-4-positive Advanced Solid Tumors With R-Star001 (Nectin-4-CART-IL18)

Phase 1 Not yet recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT06610227 2025-07-16

A Study of the RNA Tumor Vaccine Targeting MICA/B in Patients With Advanced Solid Tumors

Phase EARLY_PHASE1 Active not recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT06719362 2025-07-10

A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies

Phase 1 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT07046650 2025-07-01

Multi-cohort, Single-arm, Phase II Study of the Efficacy and Side Effects of Cisplatin Plus Gemcitabine in the Treatment of PD1 Failure or Intensive Treatment of Some Rare Tumors

Phase 2 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT06954558 2025-05-01

GUARDIAN

Phase 1 Recruiting

Other solid neoplasm

Advanced Solid Tumors